Celebrating nanoSCAN’s first year achievements
It’s time to look back on our accomplishments and milestones after the first 12 months of the nanoSCAN project! After kicking off our project with the first in-person meeting in Paris in November 2024, we have already seen some encouraging early results, from promising tests and experiments to our[…]
nanoSCAN recognized as key innovator by Innovation Radar
Great news: 4 of nanoSCAN’s innovations have been identified as key innovations by the European Commission’s Innovation Radar: Being featured on the Innovation Radar places us among a select group of high-potential, EU-funded innovators – an achievement we are truly proud of! About Innovation Radar:The Innovation Radar, an initiative[…]
Experiments and chip installation
Big project update: Andrea Bassi, Paolo Maran (both Politecnico di Milano) and Maxime Meghnagi (CNRS) are currently conducting alpha-testing experiments at CNRS/ISMO, working to install the CNR chip – a key component of the groundbreaking ModLoc technology. This marks an important step toward advancing our innovation!
First series of alpha tests completed
Exciting milestone for the nanoSCAN Project: From 30 September to 11 October, we successfully completed our first series of alpha tests for our innovative chip-based illumination technology at Abbelight and ISMO. Here we were able to integrate our photonic chips, provided by CNRS and POLIMI, into existing setups to[…]
nanoSCAN at EOSAM 2024
We are pleased to share that two members of our project team, Francesca Bragheri and Paolo Maran, delivered two presentations at the European Optical Society Annual Meeting (#EOSAM2024), held from 9-13 September in Naples, Italy! Francesca Bragheri presented her latest work on “Optofluidic integrated platform for high-throughput high-resolution imaging”,[…]
Groundbreaking SAFe-nSCAN multi-scale imaging platform to revolutionize tissue analysis
With its game-changing technology, the nanoSCAN project will provide crucial 3D spatial biology imaging insights into cell and tissue function, improving the effectiveness of cancer immunotherapy by identifying the best therapy for a patient. The project will receive around 2.49 million euro funding from the European Innovation Council programme.[…]
Kick-off meeting in Paris
We finally had the chance to meet all project partners in person, including staff from the Institute of Molecular Sciences of Orsay (ISMO, a joint research unit of the Centre national de la recherche scientifique and the Paris-Sud University (Paris XI) / Université Paris-Saclay), the Department of Physics at Politecnico di Milano, the CNR IFN (part of[…]
nanoSCAN project is funded by the EU’s HORIZON EUROPE programme under grant agreement number 101136680.
© 2025 nanoSCAN Project.